![](/img/cover-not-exists.png)
PRO118 WHAT IS THE IMPACT OF ORPHAN DRUG RE-ASSESSMENTS IN GERMANY ON THEIR ADDITIONAL BENEFIT AND PRICE?
Pownell, A.Volume:
22
Journal:
Value in Health
DOI:
10.1016/j.jval.2019.09.2448
Date:
November, 2019
File:
PDF, 386 KB
2019